首页 正文

Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?

{{output}}
Dexamethasone, a corticosteroid, has been approved for use in the treatment of severe COVID-19, which is characterised by hyperinflammation and associated lung damage. However, dexamethasone shows no clinical benefit in the treatment of less severe disease, an... ...